Skip to main content
TipRanks
Go Ultimate75% OFF

Church & Dwight (0R13) Q3 2026 Earnings Report

0 Followers

GB:0R13 Q3 2026 EPS Results

Actual EPS
$0.92
Consensus EPS
$0.90
Beat/Miss
Beat by +$0.02
One Year Ago EPS
$0.81

GB:0R13 Q3 2026 Revenue Results

Actual Revenue
$1.60B
Expected Revenue
$1.58B
Beat/Miss
Beat by +$22.85M
YoY Revenue Growth
+1.04%

Earnings Announcement Details

Quarter
Q3 2026
Date
10/30/2026
Time
Before Open
Conference Call
Friday, October 30, 2026
GB:0R13 Upcoming Earnings

Church & Dwight's next earnings date is estimated for January 29, 2027, based on past reporting schedules.

Q3 2026 Earnings Call Audio

GB:0R13 Q3 2026 Earnings Call
0:00 / 0:00

Q3 2026 Earnings Slide Deck

No slide deck is available for this earnings event.

Q3 2026 Earnings Call Summary

Q3 2026
Earnings Call Date:Oct 30, 2026|% Change Since:6.52%|
Earnings Call Sentiment|Positive

The call was strongly positive overall. The company delivered broad-based organic growth, exceeded third-quarter expectations, expanded gross margin, increased adjusted EPS by 13.6%, raised its 2026 outlook and reported strong performance across domestic, international and specialty products. The main challenges were inflation, transportation costs, elevated promotional activity, consumer pressure and slower-than-expected TOUCHLAND growth, but management described productivity, innovation, distribution gains and international expansion as important offsets.

Company Guidance

For 2026, Church & Dwight expects organic sales growth of approximately 5% at the high end of its prior range of 4% to 5%, adjusted gross margin to expand approximately 100 basis points, marketing investments to remain at approximately 11% of sales, SG&A as a percentage of sales to remain above 2025 levels, an adjusted tax rate of approximately 21%, adjusted EPS of approximately 7%, tightening on its prior range of 6% to 8%, and cash from operations of approximately $1.175 billion; the outlook includes approximately $150 million of inflation, assumes roughly a crude oil price of $100 a barrel, and the fourth quarter outlook is organic sales growth of approximately 4% and adjusted EPS expected to increase 17% to 19% versus last year. For 2027, the company expects category growth of around 2.5%, another record year for productivity, growth from TOUCHLAND, and growth initiatives to be tailwinds in '27, '28 and '29.

  • Third-Quarter Results Exceeded OutlookNet sales increased 1%, ahead of the outlook for a 1% decline. Organic sales grew 5.1%, well above the approximately 3% outlook, with growth across all three divisions. Volume increased 4.6% and price and mix contributed 0.5%.
  • Adjusted EPS and Operating Income GrowthThird-quarter adjusted EPS was $0.92, up 13.6% versus last year and above the $0.89 outlook. Adjusted income from operations increased $27 million, or 10.1%, to $298 million.
  • Gross Margin Expansion Despite Cost HeadwindsGross margin increased to 46.8%, up 170 basis points versus last year. Productivity contributed 150 basis points, acquisition mix and portfolio actions contributed 160 basis points, and volume, price, mix and FX contributed 40 basis points.
  • Broad-Based Domestic Consumer GrowthU.S. Consumer organic sales increased 4.4%, driven by 3.6% volume growth and favorable price and product mix of 0.8%. Growth was broad-based across Household and Personal Care, led by ARM & HAMMER Liquid Laundry Detergent, THERABREATH, ARM & HAMMER Cat Litter and WATERPIK.
  • ARM & HAMMER Laundry and Litter Share GainsARM & HAMMER laundry detergent consumption grew over 4% while the laundry category grew about 2%, and the brand reached record shares across total laundry. ARM & HAMMER Cat Litter consumption grew 5.4%, with share increasing 0.6 points to 24%. The DUAL DEFENSE with Microban Clumping Litter launch continued to perform well.
  • THERABREATH Reached Record ShareTHERABREATH gained 3.5 share points to reach a record 26.8% share and further solidified its number-two position in total mouthwash. THERABREATH Complete became the top-selling new rinse nationally, while household penetration remained 14% versus 65% for the mouthwash category.
  • THERABREATH Global and Toothpaste ExpansionManagement said THERABREATH mouthwash is growing double digits while the category is flat, remains within 6 or 7 share points of LISTERINE, and has strong repeat rates and growing customer loyalty. In Japan, THERABREATH reached approximately 15% to 20% of distributor Graphico's sales within 12 months or less. THERABREATH toothpaste reached a 1 share point, with repeat rate approaching 30%.
  • HERO Innovation and Acne-Care OpportunityHERO consumption outpaced the acne patch category, and the cleansers launch was described as off to a good start. Facial cleansers represent a $650 million category and approximately 30% of the total acne category, while HERO household penetration is 10% versus 30% for the category.
  • WATERPIK Delivered Double-Digit Sales GrowthWATERPIK delivered double-digit sales growth in the quarter and gained share in 2026.
  • Strong International PerformanceInternational organic sales grew 7.8%, driven by 9.1% volume growth and partially offset by lower price and product mix of 1.3%. Growth was led by THERABREATH, BATISTE, TOUCHLAND and OXICLEAN, with nine international brands delivering double-digit growth.
  • Specialty Products Continued Its Growth StreakThe Specialty Products division delivered 5% organic sales growth, including 2.9% volume growth and 2.1% higher price and product mix. This marked the 11th consecutive quarter of organic growth for the division.
  • E-Commerce Growth AcceleratedGlobal e-commerce revenue grew 20% in the quarter, and global online sales represented 25.9% of total consumer sales. Management said the company had moved from a laggard to a leader in e-commerce growth.
  • Raised 2026 Sales and EPS OutlookThe company raised its 2026 organic sales growth outlook to approximately 5%, at the high end of the prior 4% to 5% range. Adjusted EPS growth is now expected to be approximately 7%, tightening the prior 6% to 8% range.
  • Fourth-Quarter and Cash Flow OutlookFourth-quarter organic sales growth is expected to be approximately 4%, with adjusted EPS expected to increase 17% to 19% versus last year. Full-year cash from operations is expected to remain approximately $1.175 billion.
  • Strong Cash Flow Conversion and Capital FlexibilityCash from operations for the first nine months of 2026 was $841 million, representing 114% cash flow conversion. Capital expenditures totaled $92 million through the third quarter and are expected to be approximately $125 million, or about 2% of sales, for the full year. The Board authorized up to $1 billion in common stock repurchases, replacing the prior authorization.
  • Continued Investment in Brands, Growth Initiatives and CapabilitiesMarketing investment reached 11.9% of sales in the third quarter, and the full-year outlook remains approximately 11% of sales. The company is continuing investments in international, e-commerce and AI capabilities, while advancing 2030 initiatives focused on expanding ARM & HAMMER, increasing THERABREATH in oral care and scaling the international business.
  • Productivity and 2027 Margin TailwindsManagement expects record productivity in 2026 and another record year of productivity in 2027. The company also cited positive mix from innovation and portfolio actions, fixed-cost leverage as organic and reported growth become closer following the divestiture of $400 million of businesses, and continued use of its revenue growth management toolkit.
  • International M&A and Licensing PipelineThe company is evaluating acquisitions outside the U.S. and said its international M&A process is becoming more repeatable and sustainable. International targets are generally expected to be number-one or number-two brands, gross-margin accretive and asset-light, with some additional latitude regarding factories and back-office operations. Management also said one licensed brand has already been brought back in-house and two or three others are being evaluated.
  • MISS MOUTH'S Early PerformanceMISS MOUTH'S was described as off to a great start, with strong consumption numbers and strong performance during the Prime Day season. Management said it remains very optimistic about the brand.

GB:0R13 Earnings History

GB:0R13 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Jan 29, 20272026 (Q4)1.02-0.86――
Oct 30, 20262026 (Q3)0.900.920.8113.58% (+0.11)
Jul 31, 20262026 (Q2)0.900.890.94-5.32% (-0.05)
May 01, 20262026 (Q1)0.930.950.914.40% (+0.04)
Jan 30, 20262025 (Q4)0.840.860.7711.69% (+0.09)
Oct 31, 20252025 (Q3)0.740.810.792.53% (+0.02)
Aug 01, 20252025 (Q2)0.860.940.931.08% (+0.01)
May 01, 20252025 (Q1)0.900.910.96-5.21% (-0.05)
Jan 31, 20252024 (Q4)0.770.770.6518.46% (+0.12)
Nov 01, 20242024 (Q3)0.680.790.746.76% (+0.05)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed